Evogene Schedules Third Quarter 2026 Financial Results Release
Evogene Ltd. announced it will release its financial results for the third quarter of 2026 on November 19, 2026, followed by a conference call.
Stocks · News reference
EverGen Infrastructure Corp. reported record production levels of renewable natural gas (RNG) for the third quarter of 2026.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Evogene Ltd. announced it will release its financial results for the third quarter of 2026 on November 19, 2026, followed by a conference call.
Evogene Ltd. has identified acute graft-versus-host disease (aGVHD) as the primary target indication for its internal AI-driven small-molecule drug discovery program.
Evogene Ltd. announced its participation in an AI drug discovery roadshow on the U.S. East Coast, organized by the Israel Export Institute and TradeIL.
Under the terms of the Agreement, two current directors, Dr. Yael Margolin and Mr. Yoshinori Oikawa, who resigned from the Board will be replaced by Pure Capital Group nominees Dr. Adi Zuluf-Shani and Mr. Oz Adler.
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.27) by 51.85 percent. This is a 74 percent increase over losses of $(0.50) per share from the same